Drug intelligence / Profile preview

n-[(benzyloxy)carbonyl]-l-cysteinylglycine

Development stage: Unknown
Modality: Small Molecules

Overview

N-[(Benzyloxy)carbonyl]-L-cysteinylglycine is a synthetic dipeptide derivative consisting of L-cysteine and glycine residues with a benzoyloxymethyl (Cbz or Z group) protecting group on the N-terminus. It is classified as an organic compound in the dipeptide class. This compound is primarily used in research settings for peptide synthesis and as a building block in chemical biology studies. There are no known clinical indications or approved uses for this molecule[1][3].

Other names: N-[(Benzyloxy)carbonyl]-L-CysteinylglycineN-((BENZYLOXY)CARBONYL)-L-CYSTEINYLGLYCINE2-((2R)-2-(((benzyloxy)carbonyl)amino)-3-sulfanylpropanamido)acetic acid2-[(2R)-2-{[(benzyloxy)carbonyl]amino}-3-sulfanylpropanamido]acetic acidCbz-Cys-Gly-OH

Targets

MBL (Class B metallo-beta-lactamase)

Beyond the preview

Go deeper on n-[(benzyloxy)carbonyl]-l-cysteinylglycine.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on n-[(benzyloxy)carbonyl]-l-cysteinylglycine.

Explore the full profile